Cargando…
Correction: Biosynthesis of a VLP-type nanocarrier specifc to cancer cells using the BEVS expression system for targeted drug delivery
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070569/ https://www.ncbi.nlm.nih.gov/pubmed/37010668 http://dx.doi.org/10.1186/s43141-023-00485-x |
| _version_ | 1785019037575544832 |
|---|---|
| author | Hashemzadeh, Mohammad Sadegh Gharari, Nariman |
| author_facet | Hashemzadeh, Mohammad Sadegh Gharari, Nariman |
| author_sort | Hashemzadeh, Mohammad Sadegh |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10070569 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100705692023-04-05 Correction: Biosynthesis of a VLP-type nanocarrier specifc to cancer cells using the BEVS expression system for targeted drug delivery Hashemzadeh, Mohammad Sadegh Gharari, Nariman J Genet Eng Biotechnol Correction Springer Berlin Heidelberg 2023-04-03 /pmc/articles/PMC10070569/ /pubmed/37010668 http://dx.doi.org/10.1186/s43141-023-00485-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Hashemzadeh, Mohammad Sadegh Gharari, Nariman Correction: Biosynthesis of a VLP-type nanocarrier specifc to cancer cells using the BEVS expression system for targeted drug delivery |
| title | Correction: Biosynthesis of a VLP-type nanocarrier specifc to cancer cells using the BEVS expression system for targeted drug delivery |
| title_full | Correction: Biosynthesis of a VLP-type nanocarrier specifc to cancer cells using the BEVS expression system for targeted drug delivery |
| title_fullStr | Correction: Biosynthesis of a VLP-type nanocarrier specifc to cancer cells using the BEVS expression system for targeted drug delivery |
| title_full_unstemmed | Correction: Biosynthesis of a VLP-type nanocarrier specifc to cancer cells using the BEVS expression system for targeted drug delivery |
| title_short | Correction: Biosynthesis of a VLP-type nanocarrier specifc to cancer cells using the BEVS expression system for targeted drug delivery |
| title_sort | correction: biosynthesis of a vlp-type nanocarrier specifc to cancer cells using the bevs expression system for targeted drug delivery |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070569/ https://www.ncbi.nlm.nih.gov/pubmed/37010668 http://dx.doi.org/10.1186/s43141-023-00485-x |
| work_keys_str_mv | AT hashemzadehmohammadsadegh correctionbiosynthesisofavlptypenanocarrierspecifctocancercellsusingthebevsexpressionsystemfortargeteddrugdelivery AT ghararinariman correctionbiosynthesisofavlptypenanocarrierspecifctocancercellsusingthebevsexpressionsystemfortargeteddrugdelivery |